The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

In Brief

Cheryl L. Willman named Stephen and Barbara Slaggie Executive Director of Mayo Clinic Cancer Programs, director of Mayo Clinic Comprehensive Cancer Center

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
BYLINE
IN THIS ISSUE
DOWNLOAD PDFTABLE OF CONTENTS
Cheryl L. Willman

Cheryl L. Willman was named Stephen and Barbara Slaggie Executive Director of Mayo Clinic Cancer Programs and director of Mayo Clinic Comprehensive Cancer Center following a gift from Stephen M. and Barbara J. Slaggie of Marco Island, FL, and Winona, MN.

Willman previously became the executive director of Mayo Clinic Cancer Programs and director of Mayo Clinic Comprehensive Cancer Center in August 2021 (The Cancer Letter, May 21, 2021). 

Mr. and Mrs. Slaggie are longtime Mayo Clinic patients who have expressed appreciation for the Mayo Clinic Model of Care and for the care provided to them and their family over the years.

Table of Contents

YOU MAY BE INTERESTED IN

Clinical Roundup

Mayo Clinic researchers use milk-derived nanoparticles to target aggressive bile duct cancer

Mayo Clinic researchers have developed a promising way to deliver treatment directly to cholangiocarcinoma tumors, a rare and aggressive bile duct cancer with limited treatment options, using milk-derived nanoparticles that act like guided delivery vehicles. The study points to a potential targeted genetic therapy designed to attack cancer cells while sparing healthy tissue.
Table of Contents

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account